Protection of sensory function in diabetic rats by Neotrofin
- 18 March 2006
- journal article
- research article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 534 (1-3) , 187-193
- https://doi.org/10.1016/j.ejphar.2006.01.047
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- Prevention of sensory disorders in diabetic Sprague-Dawley rats by aldose reductase inhibition or treatment with ciliary neurotrophic factorDiabetologia, 2004
- Erythropoietin both protects from and reverses experimental diabetic neuropathyProceedings of the National Academy of Sciences, 2004
- Restorative effects of neurotrophin treatment on diabetes-induced cutaneous axon loss in miceExperimental Neurology, 2003
- Efficacy and Safety of Recombinant Human Nerve Growth Factor in Patients With Diabetic PolyneuropathyJAMA, 2000
- Impaired Nociception and Pain Sensation in Mice Lacking the Capsaicin ReceptorScience, 2000
- Elevated substance-P-like immunoreactivity levels in spinal dialysates during the formalin test in normal and diabetic ratsBrain Research, 2000
- Prosaposin Gene Expression and the Efficacy of a Prosaposin-derived Peptide in Preventing Structural and Functional Disorders of Peripheral Nerve in Diabetic RatsJournal of Neuropathology and Experimental Neurology, 1999
- The role of endogenous nerve growth factor in human diabetic neuropathyNature Medicine, 1996
- Nerve growth factor administration protects against experimental diabetic sensory neuropathyBrain Research, 1994
- Reduced ciliary neuronotrophic factor-like activity in nerves from diabetic or galactose-fed ratsBrain Research, 1992